A Potassium-Competitive Acid Blocker-Based Regimen as Second-Line Therapy Improves < b > < i > Helicobacter pylori < /i > < /b > Eradication
Conclusions: PCAB-based second-lineH. pylori eradication is significantly better than PPI-based therapy.Digestion
Source: Digestion - Category: Gastroenterology Source Type: research
More News: Amoxicillin | Gastroenterology | Helicobacter Pylori | Metronidazole | Potassium | Proton Pump Inhibitors PPIs | Study